In fiscal year 2025, Orum Therapeutics (475830) reported revenue of 24 million KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 24 million KRW | -51.8 billion KRW | -42.0 billion KRW | [source] |
| 2024 | 20.9 billion KRW | -8.3 billion KRW | -5.7 billion KRW | [source] |
| 2023 | 135.4 billion KRW | 95.6 billion KRW | 68.2 billion KRW | — |
| 2022 | 76 million KRW | -43.6 billion KRW | -63.3 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 148.6 billion KRW | 29.0 billion KRW | 119.5 billion KRW | [source] |
| 2024 | 157.6 billion KRW | 43.5 billion KRW | 114.1 billion KRW | [source] |
| 2023 | — | — | — | — |
| 2022 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.